# Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.

> **NCT05816681** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 60 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **DRUG:** DWJ1230
- **DRUG:** DWB2001

## Key facts

- **NCT ID:** NCT05816681
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-22
- **Primary completion:** 2023-02-06
- **Final completion:** 2023-04-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05816681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05816681, "Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT05816681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*